Reagent for the determination of nobiagen fibrinogen protein decomposition of hydrostasis
Taiwan·Risk Class 2·SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT·Registered Mar 29, 2006 – Mar 29, 2026Expired- Analysis ID
- 84bd1d063b0517665ba1f93876a065df
- Customs Code
- DHA00601626200
- Manufacturer
- SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT
- Manufacturer Country
- Japan
- Authorized Representative
- KUO'S YUAN IN ENTERPRISE CO., LTD.
- Intended Use
- Determination of fibrinogen protein decomposition in serum or plasma.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.7320 Fibrinogen/Fibrinolysis Product Analysis
- Import Information
- import
- Registration Date
- Mar 29, 2006
- Expiry Date
- Mar 29, 2026
Access comprehensive regulatory information for Reagent for the determination of nobiagen fibrinogen protein decomposition of hydrostasis in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 84bd1d063b0517665ba1f93876a065df and manufactured by SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.